• レポートコード:QY2108PAL0727 • 出版社/出版日:QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、112ページ • 納品方法:Eメール(納期:3日) • 産業分類:化学&材料 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はカナグリフロジンAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。カナグリフロジンAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(純度≥98%、純度<98%)、用途別市場規模(カナグリフロジン錠、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・カナグリフロジンAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・カナグリフロジンAPIの種類別市場規模:純度≥98%、純度<98% ・カナグリフロジンAPIの用途別市場規模:カナグリフロジン錠、その他 ・北米のカナグリフロジンAPI市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ) ・ヨーロッパのカナグリフロジンAPI市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス) ・アジアのカナグリフロジンAPI市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国) ・中南米のカナグリフロジンAPI市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル) ・中東・アフリカのカナグリフロジンAPI市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア) ・企業情報:Dr. Reddy's Laboratories、Metrochem API Private Limited、Sun Pharmaceutical、Zhejiang Huahai Pharmaceutical、Indoco Remedies Ltd.、Lupin Ltd、CAD Middle East Pharmaceutical Industries LLC、Melody Healthcare Pvt Ltd、Changzhou Pharmaceutical Factory、Glenmark Pharmaceuticals ・カナグリフロジンAPIのバリューチェーン・販売チャネル分析 ・カナグリフロジンAPIの世界市場動向 |
Canagliflozin is a C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It is a C-glycosyl compound, a member of thiophenes and an organofluorine compound.
Market Analysis and Insights: Global Canagliflozin API Market
The global Canagliflozin API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Canagliflozin API Scope and Segment
Canagliflozin API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Canagliflozin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Canagliflozin Tablets
Others
By Company
Dr. Reddy's Laboratories
Metrochem API Private Limited
Sun Pharmaceutical
Zhejiang Huahai Pharmaceutical
Indoco Remedies Ltd.
Lupin Ltd
CAD Middle East Pharmaceutical Industries LLC
Melody Healthcare Pvt Ltd
Changzhou Pharmaceutical Factory
Glenmark Pharmaceuticals
Production by Region
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Canagliflozin API Product Introduction
1.2 Market by Type
1.2.1 Global Canagliflozin API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Market by Application
1.3.1 Global Canagliflozin API Market Size Growth Rate by Application
1.3.2 Canagliflozin Tablets
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Canagliflozin API Production
2.1 Global Canagliflozin API Production Capacity (2016-2027)
2.2 Global Canagliflozin API Production by Region: 2016 VS 2021 VS 2027
2.3 Global Canagliflozin API Production by Region
2.3.1 Global Canagliflozin API Historic Production by Region (2016-2021)
2.3.2 Global Canagliflozin API Forecasted Production by Region (2022-2027)
2.4 China
2.5 India
3 Global Canagliflozin API Sales in Volume & Value Estimates and Forecasts
3.1 Global Canagliflozin API Sales Estimates and Forecasts 2016-2027
3.2 Global Canagliflozin API Revenue Estimates and Forecasts 2016-2027
3.3 Global Canagliflozin API Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Canagliflozin API Regions by Sales
3.4.1 Global Top Canagliflozin API Regions by Sales (2016-2021)
3.4.2 Global Top Canagliflozin API Regions by Sales (2022-2027)
3.5 Global Top Canagliflozin API Regions by Revenue
3.5.1 Global Top Canagliflozin API Regions by Revenue (2016-2021)
3.5.2 Global Top Canagliflozin API Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Canagliflozin API Production Capacity by Manufacturers
4.2 Global Canagliflozin API Sales by Manufacturers
4.2.1 Global Top Canagliflozin API Manufacturers by Sales (2016-2021)
4.2.2 Global Top Canagliflozin API Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Canagliflozin API Sales in 2020
4.3 Global Canagliflozin API Revenue by Manufacturers
4.3.1 Global Top Canagliflozin API Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Canagliflozin API Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Canagliflozin API Revenue in 2020
4.4 Global Canagliflozin API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Canagliflozin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Canagliflozin API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Canagliflozin API Sales by Type
5.1.1 Global Canagliflozin API Historical Sales by Type (2016-2021)
5.1.2 Global Canagliflozin API Forecasted Sales by Type (2022-2027)
5.1.3 Global Canagliflozin API Sales Market Share by Type (2016-2027)
5.2 Global Canagliflozin API Revenue by Type
5.2.1 Global Canagliflozin API Historical Revenue by Type (2016-2021)
5.2.2 Global Canagliflozin API Forecasted Revenue by Type (2022-2027)
5.2.3 Global Canagliflozin API Revenue Market Share by Type (2016-2027)
5.3 Global Canagliflozin API Price by Type
5.3.1 Global Canagliflozin API Price by Type (2016-2021)
5.3.2 Global Canagliflozin API Price Forecast by Type (2022-2027)
6 Market Size by Application
6.1 Global Canagliflozin API Sales by Application
6.1.1 Global Canagliflozin API Historical Sales by Application (2016-2021)
6.1.2 Global Canagliflozin API Forecasted Sales by Application (2022-2027)
6.1.3 Global Canagliflozin API Sales Market Share by Application (2016-2027)
6.2 Global Canagliflozin API Revenue by Application
6.2.1 Global Canagliflozin API Historical Revenue by Application (2016-2021)
6.2.2 Global Canagliflozin API Forecasted Revenue by Application (2022-2027)
6.2.3 Global Canagliflozin API Revenue Market Share by Application (2016-2027)
6.3 Global Canagliflozin API Price by Application
6.3.1 Global Canagliflozin API Price by Application (2016-2021)
6.3.2 Global Canagliflozin API Price Forecast by Application (2022-2027)
7 North America
7.1 North America Canagliflozin API Market Size by Type
7.1.1 North America Canagliflozin API Sales by Type (2016-2027)
7.1.2 North America Canagliflozin API Revenue by Type (2016-2027)
7.2 North America Canagliflozin API Market Size by Application
7.2.1 North America Canagliflozin API Sales by Application (2016-2027)
7.2.2 North America Canagliflozin API Revenue by Application (2016-2027)
7.3 North America Canagliflozin API Sales by Country
7.3.1 North America Canagliflozin API Sales by Country (2016-2027)
7.3.2 North America Canagliflozin API Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Canagliflozin API Market Size by Type
8.1.1 Europe Canagliflozin API Sales by Type (2016-2027)
8.1.2 Europe Canagliflozin API Revenue by Type (2016-2027)
8.2 Europe Canagliflozin API Market Size by Application
8.2.1 Europe Canagliflozin API Sales by Application (2016-2027)
8.2.2 Europe Canagliflozin API Revenue by Application (2016-2027)
8.3 Europe Canagliflozin API Sales by Country
8.3.1 Europe Canagliflozin API Sales by Country (2016-2027)
8.3.2 Europe Canagliflozin API Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Canagliflozin API Market Size by Type
9.1.1 Asia Pacific Canagliflozin API Sales by Type (2016-2027)
9.1.2 Asia Pacific Canagliflozin API Revenue by Type (2016-2027)
9.2 Asia Pacific Canagliflozin API Market Size by Application
9.2.1 Asia Pacific Canagliflozin API Sales by Application (2016-2027)
9.2.2 Asia Pacific Canagliflozin API Revenue by Application (2016-2027)
9.3 Asia Pacific Canagliflozin API Sales by Region
9.3.1 Asia Pacific Canagliflozin API Sales by Region (2016-2027)
9.3.2 Asia Pacific Canagliflozin API Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Canagliflozin API Market Size by Type
10.1.1 Latin America Canagliflozin API Sales by Type (2016-2027)
10.1.2 Latin America Canagliflozin API Revenue by Type (2016-2027)
10.2 Latin America Canagliflozin API Market Size by Application
10.2.1 Latin America Canagliflozin API Sales by Application (2016-2027)
10.2.2 Latin America Canagliflozin API Revenue by Application (2016-2027)
10.3 Latin America Canagliflozin API Sales by Country
10.3.1 Latin America Canagliflozin API Sales by Country (2016-2027)
10.3.2 Latin America Canagliflozin API Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Canagliflozin API Market Size by Type
11.1.1 Middle East and Africa Canagliflozin API Sales by Type (2016-2027)
11.1.2 Middle East and Africa Canagliflozin API Revenue by Type (2016-2027)
11.2 Middle East and Africa Canagliflozin API Market Size by Application
11.2.1 Middle East and Africa Canagliflozin API Sales by Application (2016-2027)
11.2.2 Middle East and Africa Canagliflozin API Revenue by Application (2016-2027)
11.3 Middle East and Africa Canagliflozin API Sales by Country
11.3.1 Middle East and Africa Canagliflozin API Sales by Country (2016-2027)
11.3.2 Middle East and Africa Canagliflozin API Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Dr. Reddy's Laboratories
12.1.1 Dr. Reddy's Laboratories Corporation Information
12.1.2 Dr. Reddy's Laboratories Overview
12.1.3 Dr. Reddy's Laboratories Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Dr. Reddy's Laboratories Canagliflozin API Product Description
12.1.5 Dr. Reddy's Laboratories Recent Developments
12.2 Metrochem API Private Limited
12.2.1 Metrochem API Private Limited Corporation Information
12.2.2 Metrochem API Private Limited Overview
12.2.3 Metrochem API Private Limited Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Metrochem API Private Limited Canagliflozin API Product Description
12.2.5 Metrochem API Private Limited Recent Developments
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Corporation Information
12.3.2 Sun Pharmaceutical Overview
12.3.3 Sun Pharmaceutical Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Canagliflozin API Product Description
12.3.5 Sun Pharmaceutical Recent Developments
12.4 Zhejiang Huahai Pharmaceutical
12.4.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.4.2 Zhejiang Huahai Pharmaceutical Overview
12.4.3 Zhejiang Huahai Pharmaceutical Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Zhejiang Huahai Pharmaceutical Canagliflozin API Product Description
12.4.5 Zhejiang Huahai Pharmaceutical Recent Developments
12.5 Indoco Remedies Ltd.
12.5.1 Indoco Remedies Ltd. Corporation Information
12.5.2 Indoco Remedies Ltd. Overview
12.5.3 Indoco Remedies Ltd. Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Indoco Remedies Ltd. Canagliflozin API Product Description
12.5.5 Indoco Remedies Ltd. Recent Developments
12.6 Lupin Ltd
12.6.1 Lupin Ltd Corporation Information
12.6.2 Lupin Ltd Overview
12.6.3 Lupin Ltd Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Lupin Ltd Canagliflozin API Product Description
12.6.5 Lupin Ltd Recent Developments
12.7 CAD Middle East Pharmaceutical Industries LLC
12.7.1 CAD Middle East Pharmaceutical Industries LLC Corporation Information
12.7.2 CAD Middle East Pharmaceutical Industries LLC Overview
12.7.3 CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Product Description
12.7.5 CAD Middle East Pharmaceutical Industries LLC Recent Developments
12.8 Melody Healthcare Pvt Ltd
12.8.1 Melody Healthcare Pvt Ltd Corporation Information
12.8.2 Melody Healthcare Pvt Ltd Overview
12.8.3 Melody Healthcare Pvt Ltd Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 Melody Healthcare Pvt Ltd Canagliflozin API Product Description
12.8.5 Melody Healthcare Pvt Ltd Recent Developments
12.9 Changzhou Pharmaceutical Factory
12.9.1 Changzhou Pharmaceutical Factory Corporation Information
12.9.2 Changzhou Pharmaceutical Factory Overview
12.9.3 Changzhou Pharmaceutical Factory Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 Changzhou Pharmaceutical Factory Canagliflozin API Product Description
12.9.5 Changzhou Pharmaceutical Factory Recent Developments
12.10 Glenmark Pharmaceuticals
12.10.1 Glenmark Pharmaceuticals Corporation Information
12.10.2 Glenmark Pharmaceuticals Overview
12.10.3 Glenmark Pharmaceuticals Canagliflozin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Glenmark Pharmaceuticals Canagliflozin API Product Description
12.10.5 Glenmark Pharmaceuticals Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Canagliflozin API Industry Chain Analysis
13.2 Canagliflozin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Canagliflozin API Production Mode & Process
13.4 Canagliflozin API Sales and Marketing
13.4.1 Canagliflozin API Sales Channels
13.4.2 Canagliflozin API Distributors
13.5 Canagliflozin API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Canagliflozin API Industry Trends
14.2 Canagliflozin API Market Drivers
14.3 Canagliflozin API Market Challenges
14.4 Canagliflozin API Market Restraints
15 Key Finding in The Global Canagliflozin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Canagliflozin API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Canagliflozin API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Canagliflozin API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Canagliflozin API Production by Region (2016-2021) & (Ton)
Table 7. Global Canagliflozin API Production Market Share by Region (2016-2021)
Table 8. Global Canagliflozin API Production by Region (2022-2027) & (Ton)
Table 9. Global Canagliflozin API Production Market Share by Region (2022-2027)
Table 10. Global Canagliflozin API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Canagliflozin API Sales by Region (2016-2021) & (Ton)
Table 12. Global Canagliflozin API Sales Market Share by Region (2016-2021)
Table 13. Global Canagliflozin API Sales by Region (2022-2027) & (Ton)
Table 14. Global Canagliflozin API Sales Market Share by Region (2022-2027)
Table 15. Global Canagliflozin API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Canagliflozin API Revenue Market Share by Region (2016-2021)
Table 17. Global Canagliflozin API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Canagliflozin API Revenue Market Share by Region (2022-2027)
Table 19. Global Canagliflozin API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Canagliflozin API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Canagliflozin API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Canagliflozin API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Canagliflozin API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Canagliflozin API Sales Share by Manufacturers (2016-2021)
Table 25. Global Canagliflozin API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Canagliflozin API Revenue Share by Manufacturers (2016-2021)
Table 27. Canagliflozin API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Canagliflozin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Canagliflozin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canagliflozin API as of 2020)
Table 30. Canagliflozin API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Canagliflozin API Product Offered
Table 32. Date of Manufacturers Enter into Canagliflozin API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Canagliflozin API Sales by Type (2016-2021) & (Ton)
Table 35. Global Canagliflozin API Sales by Type (2022-2027) & (Ton)
Table 36. Global Canagliflozin API Sales Share by Type (2016-2021)
Table 37. Global Canagliflozin API Sales Share by Type (2022-2027)
Table 38. Global Canagliflozin API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Canagliflozin API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Canagliflozin API Revenue Share by Type (2016-2021)
Table 41. Global Canagliflozin API Revenue Share by Type (2022-2027)
Table 42. Canagliflozin API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Canagliflozin API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Canagliflozin API Sales by Application (2016-2021) & (Ton)
Table 45. Global Canagliflozin API Sales by Application (2022-2027) & (Ton)
Table 46. Global Canagliflozin API Sales Share by Application (2016-2021)
Table 47. Global Canagliflozin API Sales Share by Application (2022-2027)
Table 48. Global Canagliflozin API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Canagliflozin API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Canagliflozin API Revenue Share by Application (2016-2021)
Table 51. Global Canagliflozin API Revenue Share by Application (2022-2027)
Table 52. Canagliflozin API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Canagliflozin API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Canagliflozin API Sales by Type (2016-2021) & (Ton)
Table 55. North America Canagliflozin API Sales by Type (2022-2027) & (Ton)
Table 56. North America Canagliflozin API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Canagliflozin API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Canagliflozin API Sales by Application (2016-2021) & (Ton)
Table 59. North America Canagliflozin API Sales by Application (2022-2027) & (Ton)
Table 60. North America Canagliflozin API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Canagliflozin API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Canagliflozin API Sales by Country (2016-2021) & (Ton)
Table 63. North America Canagliflozin API Sales by Country (2022-2027) & (Ton)
Table 64. North America Canagliflozin API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Canagliflozin API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Canagliflozin API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Canagliflozin API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Canagliflozin API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Canagliflozin API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Canagliflozin API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Canagliflozin API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Canagliflozin API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Canagliflozin API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Canagliflozin API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Canagliflozin API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Canagliflozin API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Canagliflozin API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Canagliflozin API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Canagliflozin API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Canagliflozin API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Canagliflozin API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Canagliflozin API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Canagliflozin API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Canagliflozin API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Canagliflozin API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Canagliflozin API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Canagliflozin API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Canagliflozin API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Canagliflozin API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Canagliflozin API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Canagliflozin API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Canagliflozin API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Canagliflozin API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Canagliflozin API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Canagliflozin API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Canagliflozin API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Canagliflozin API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Canagliflozin API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Canagliflozin API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Canagliflozin API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Canagliflozin API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Canagliflozin API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Canagliflozin API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Canagliflozin API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Canagliflozin API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Canagliflozin API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Canagliflozin API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Canagliflozin API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Canagliflozin API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Canagliflozin API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Canagliflozin API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Canagliflozin API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Canagliflozin API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy's Laboratories Corporation Information
Table 115. Dr. Reddy's Laboratories Description and Major Businesses
Table 116. Dr. Reddy's Laboratories Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy's Laboratories Canagliflozin API Product
Table 118. Dr. Reddy's Laboratories Recent Development
Table 119. Metrochem API Private Limited Corporation Information
Table 120. Metrochem API Private Limited Description and Major Businesses
Table 121. Metrochem API Private Limited Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Metrochem API Private Limited Canagliflozin API Product
Table 123. Metrochem API Private Limited Recent Development
Table 124. Sun Pharmaceutical Corporation Information
Table 125. Sun Pharmaceutical Description and Major Businesses
Table 126. Sun Pharmaceutical Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Sun Pharmaceutical Canagliflozin API Product
Table 128. Sun Pharmaceutical Recent Development
Table 129. Zhejiang Huahai Pharmaceutical Corporation Information
Table 130. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 131. Zhejiang Huahai Pharmaceutical Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Zhejiang Huahai Pharmaceutical Canagliflozin API Product
Table 133. Zhejiang Huahai Pharmaceutical Recent Development
Table 134. Indoco Remedies Ltd. Corporation Information
Table 135. Indoco Remedies Ltd. Description and Major Businesses
Table 136. Indoco Remedies Ltd. Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Indoco Remedies Ltd. Canagliflozin API Product
Table 138. Indoco Remedies Ltd. Recent Development
Table 139. Lupin Ltd Corporation Information
Table 140. Lupin Ltd Description and Major Businesses
Table 141. Lupin Ltd Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Lupin Ltd Canagliflozin API Product
Table 143. Lupin Ltd Recent Development
Table 144. CAD Middle East Pharmaceutical Industries LLC Corporation Information
Table 145. CAD Middle East Pharmaceutical Industries LLC Description and Major Businesses
Table 146. CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Product
Table 148. CAD Middle East Pharmaceutical Industries LLC Recent Development
Table 149. Melody Healthcare Pvt Ltd Corporation Information
Table 150. Melody Healthcare Pvt Ltd Description and Major Businesses
Table 151. Melody Healthcare Pvt Ltd Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Melody Healthcare Pvt Ltd Canagliflozin API Product
Table 153. Melody Healthcare Pvt Ltd Recent Development
Table 154. Changzhou Pharmaceutical Factory Corporation Information
Table 155. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 156. Changzhou Pharmaceutical Factory Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Changzhou Pharmaceutical Factory Canagliflozin API Product
Table 158. Changzhou Pharmaceutical Factory Recent Development
Table 159. Glenmark Pharmaceuticals Corporation Information
Table 160. Glenmark Pharmaceuticals Description and Major Businesses
Table 161. Glenmark Pharmaceuticals Canagliflozin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Glenmark Pharmaceuticals Canagliflozin API Product
Table 163. Glenmark Pharmaceuticals Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Canagliflozin API Distributors List
Table 167. Canagliflozin API Customers List
Table 168. Canagliflozin API Market Trends
Table 169. Canagliflozin API Market Drivers
Table 170. Canagliflozin API Market Challenges
Table 171. Canagliflozin API Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Canagliflozin API Product Picture
Figure 2. Global Canagliflozin API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Canagliflozin API Market Share by Application in 2020 & 2027
Figure 6. Canagliflozin Tablets
Figure 7. Others
Figure 8. Canagliflozin API Report Years Considered
Figure 9. Global Canagliflozin API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Canagliflozin API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Canagliflozin API Production Market Share by Region (2016-2021)
Figure 12. Global Canagliflozin API Production Market Share by Region (2022-2027)
Figure 13. Canagliflozin API Production Growth Rate in China (2016-2027) & (Ton)
Figure 14. Canagliflozin API Production Growth Rate in India (2016-2027) & (Ton)
Figure 15. Global Canagliflozin API Sales 2016-2027 (Ton)
Figure 16. Global Canagliflozin API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Canagliflozin API Revenue 2016-2027 (US$ Million)
Figure 18. Global Canagliflozin API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 19. Global Canagliflozin API Sales Market Share by Region (2016-2021)
Figure 20. Global Canagliflozin API Sales Market Share by Region (2022-2027)
Figure 21. North America Canagliflozin API Sales YoY (2016-2027) & (Ton)
Figure 22. North America Canagliflozin API Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Europe Canagliflozin API Sales YoY (2016-2027) & (Ton)
Figure 24. Europe Canagliflozin API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Asia-Pacific Canagliflozin API Sales YoY (2016-2027) & (Ton)
Figure 26. Asia-Pacific Canagliflozin API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Latin America Canagliflozin API Sales YoY (2016-2027) & (Ton)
Figure 28. Latin America Canagliflozin API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Middle East & Africa Canagliflozin API Sales YoY (2016-2027) & (Ton)
Figure 30. Middle East & Africa Canagliflozin API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Canagliflozin API Sales in 2020
Figure 32. The Top 10 and Top 5 Players Market Share by Canagliflozin API Revenue in 2020
Figure 33. Canagliflozin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 34. Global Canagliflozin API Sales Market Share by Type (2016-2027)
Figure 35. Global Canagliflozin API Revenue Market Share by Type (2016-2027)
Figure 36. Global Canagliflozin API Sales Market Share by Application (2016-2027)
Figure 37. Global Canagliflozin API Revenue Market Share by Application (2016-2027)
Figure 38. North America Canagliflozin API Sales Market Share by Type (2016-2027)
Figure 39. North America Canagliflozin API Revenue Market Share by Type (2016-2027)
Figure 40. North America Canagliflozin API Sales Market Share by Application (2016-2027)
Figure 41. North America Canagliflozin API Revenue Market Share by Application (2016-2027)
Figure 42. North America Canagliflozin API Sales Share by Country (2016-2027)
Figure 43. North America Canagliflozin API Revenue Share by Country (2016-2027)
Figure 44. United States Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 45. Canada Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 46. Europe Canagliflozin API Sales Market Share by Type (2016-2027)
Figure 47. Europe Canagliflozin API Revenue Market Share by Type (2016-2027)
Figure 48. Europe Canagliflozin API Sales Market Share by Application (2016-2027)
Figure 49. Europe Canagliflozin API Revenue Market Share by Application (2016-2027)
Figure 50. Europe Canagliflozin API Sales Share by Country (2016-2027)
Figure 51. Europe Canagliflozin API Revenue Share by Country (2016-2027)
Figure 52. Germany Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 53. France Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 54. U.K. Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 55. Italy Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 56. Russia Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 57. Asia Pacific Canagliflozin API Sales Market Share by Type (2016-2027)
Figure 58. Asia Pacific Canagliflozin API Revenue Market Share by Type (2016-2027)
Figure 59. Asia Pacific Canagliflozin API Sales Market Share by Application (2016-2027)
Figure 60. Asia Pacific Canagliflozin API Revenue Market Share by Application (2016-2027)
Figure 61. Asia Pacific Canagliflozin API Sales Share by Region (2016-2027)
Figure 62. Asia Pacific Canagliflozin API Revenue Share by Region (2016-2027)
Figure 63. China Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 64. Japan Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 65. South Korea Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 66. India Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 67. Australia Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 68. China Taiwan Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 69. Indonesia Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 70. Thailand Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 71. Malaysia Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 72. Latin America Canagliflozin API Sales Market Share by Type (2016-2027)
Figure 73. Latin America Canagliflozin API Revenue Market Share by Type (2016-2027)
Figure 74. Latin America Canagliflozin API Sales Market Share by Application (2016-2027)
Figure 75. Latin America Canagliflozin API Revenue Market Share by Application (2016-2027)
Figure 76. Latin America Canagliflozin API Sales Share by Country (2016-2027)
Figure 77. Latin America Canagliflozin API Revenue Share by Country (2016-2027)
Figure 78. Mexico Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 79. Brazil Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 80. Argentina Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 81. Colombia Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 82. Middle East and Africa Canagliflozin API Sales Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Canagliflozin API Revenue Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Canagliflozin API Sales Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Canagliflozin API Revenue Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Canagliflozin API Sales Share by Country (2016-2027)
Figure 87. Middle East and Africa Canagliflozin API Revenue Share by Country (2016-2027)
Figure 88. Turkey Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 89. Saudi Arabia Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 90. UAE Canagliflozin API Revenue (2016-2027) & (US$ Million)
Figure 91. Canagliflozin API Value Chain
Figure 92. Canagliflozin API Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed